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Abstract There have been a small number of investigations of alexithymia in multiple sclerosis 
(MS) using the 20-item Toronto Alexithymia Scale (TAS-20). However, the TAS-20 factor structure 
has not yet been evaluated in a MS patient sample, and earlier Spanish translations of this 
instrument require some improvement. We aimed to evaluate the factorial validity and 
reliability of an improved Spanish translation of the TAS-20 (the TAS-20-S). The TAS-20-S was 
completed by 221 MS patients. Confirmatory factor analysis was used to compare the fit of six 
different factor models. Internal consistency and retest reliability coefficients were also 
computed. The correlated three-factor model and the higher-order factor model made up of 
Difficulty Identifying Feelings, Difficulty Describing Feelings, and Externally Oriented Thinking 
achieved the best fit. Alpha coefficients ranged between .87 and .67; mean inter-item 
correlations ranged between .48 and .20; and retest correlations after 6 months ranged between 
.61 and .52. A high degree of alexithymia was present in 18.1% of the sample. Reliability and the 
traditional three-factor structure were demonstrated for the TAS-20-S, which can now be 
recommended for assessing an aspect of emotional processing in MS patients.
© 2013 Asociación Española de Psicología Conductual. Published by Elsevier España, S.L.  
All rights reserved.
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Resumen En la esclerosis múltiple (EM) son escasas las investigaciones centradas en evaluar la 
alexitimia con la Escala de Alexitimia de Toronto (TAS-20). A pesar de ello, no se ha evaluado 
aún su estructura factorial en dicha población y, además, las anteriores traducciones al español 
necesitan modificaciones. Los objetivos del presente estudio fueron evaluar la validez factorial 
y la fiabilidad de una traducción mejorada en español de la TAS-20 (la TAS-20-S), la cual fue 
administrada en una muestra de 221 pacientes con EM. Se realizaron análisis factoriales confir-
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Alexithymia is a multifaceted dimensional personality 
construct that reflects a disturbance in affective information 
processing and social-cognitive functioning (Taylor & Bagby, 
2012; Wingbermühle, Theunissen, Verhoeven, Kessels, & 
Egger, 2012). This construct encompasses difficulties in 
identifying subjective feelings and differentiating between 
feelings and the somatic sensations associated with 
emotional arousal, difficulty verbalizing emotional feelings 
to others, a restricted imaginal capacity, and an externally-
oriented style of thinking (Taylor, Bagby, & Parker, 1997). 
There may also be associated impairments in recognizing 
emotions in human facial expressions, as demonstrated in 
studies with healthy volunteers (Kano, Fukudo, & Gyoba, 
2003) and multiple sclerosis patients (Prochnow et al., 
2011). 
Despite empirical evidence that alexithymia, and other 
related concepts, are associated with a wide variety of 
medical and psychopathological disorders and 
symptomatology (Balluerka, Aritzeta, Gorostiaga, Gartzia, 
& Soroa, 2013; Pascual, Etxebarria, Cruz, & Echeburúa, 
2011; Taylor & Bagby, 2012; Taylor et al., 1997), the 
construct has been scarcely investigated in multiple 
sclerosis (MS). This is somewhat surprising given recent 
findings that this personality trait is a strong predictor of 
the most quality-of-life disabling condition in MS, namely, 
depression (Bodini et al., 2008; Feinstein, 2011; Gay, 
Vrignaud, Garitte, & Meunier, 2010). The strong association 
between depression and alexithymia in MS might be 
explained partly by evidence that negative emotions are 
processed predominantly by neocortical areas in the right 
hemisphere (Adolphs, Jansari, & Tranel, 2001), which have 
been found to show reduced activation in response to 
emotional stimuli in individuals with high degrees of 
alexithymia (Kano et al., 2003), thereby contributing to 
deficits in the cognitive processing and regulation of 
negative affects. 
The objectives of the few empirical studies that assessed 
alexithymia in MS patients were to identify the facets of 
the construct that are most relevant to MS (Bodini et al., 
2008; Chahraoui et al., 2008; Gay et al., 2010), and to 
estimate the prevalence of alexithymia among MS patients, 
although the samples in these studies were small in size (58 
to 115 patients). In pursuing these objectives, alexithymia 
was measured with the 20-item Toronto Alexithymia Scale 
(TAS-20) (Bagby, Parker, & Taylor, 1994), which is the most 
frequently and widely-used instrument for assessing the 
construct (Taylor & Bagby, 2012). This self-report scale is 
comprised of three factor scales that assess difficulty 
identifying feelings, difficulty describing feelings to others, 
and externally-oriented thinking. The TAS-20 has been 
translated into more than 24 different languages, and 
validated in clinical and/or nonclinical samples in Western, 
Eastern-European, East-Asian, and Middle-Eastern countries 
(Taylor & Bagby, 2012; Taylor, Bagby, & Parker, 2003). 
To our knowledge, there are three existing Spanish 
adaptations of the TAS-20, two of which were developed in 
Latin-American countries – Mexico (Pérez-Rincón et al., 
1997) and Peru (Loiselle & Cossette, 2001) – and one 
developed in Spain (Martínez-Sánchez, 1996; Páez et al., 
1999). These adaptations of the scale have certain 
limitations. For example, the Mexican and Peruvian versions 
present some dialectical particularities when compared 
with the Spanish spoken in Spain. In addition, the Latin-
American versions, and also the version developed in Spain, 
contain some items whose back-translation does not 
adequately reflect the meanings of the original English 
version of the items. Moreover, the indices and criteria 
used to evaluate goodness of fit of the three-factor model 
of the Spanish translations of the TAS-20 do not meet the 
standards that are currently employed in psychometric 
studies and recommended in Hu and Bentler’s (1999) 
guidelines.
Some investigators have obtained a different factor 
structure for the TAS-20 in studies with patient samples 
(Kooiman, Spinhoven, & Trijsburg, 2002; Müller, Bühner, & 
Ellgring, 2003; Pérez-Rincón et al., 1997), suggesting that 
the factor structure might depend on the specific sample 
analyzed. Although a few studies have used the TAS-20 to 
assess alexithymia in MS patients, the reliability and three-
factor structure of the scale have not yet been evaluated 
in this population. It is important to address this deficiency 
not merely to satisfy professionals in the measurement 
field (Carretero-Dios & Pérez, 2007), but also for clinical 
reasons as evidence for the validity of the scale will allow 
researchers to identify which of the TAS-20 factor scales 
are differentially related to other clinical outcomes in a 
more meaningful way (Briggs & Cheek, 1986). There is 
evidence, for example, that the Difficulty Identifying 
Feelings factor scale of the TAS-20 is stronger than the 
total scale in predicting fatigue and depression in MS 
patients (Bodini et al., 2008). 
Given the above considerations, the aim of this 
instrumental study (Montero & León, 2007) was to work 
collaboratively with the developers of the original English 
matorios para comparar el ajuste de seis modelos factoriales. También se calcularon coefi-
cientes de consistencia interna y de fiabilidad test-retest. Los modelos trifactorial correlacio-
nado y el de orden superior conformados por Dificultad en Identificar Sentimientos, Dificultad 
en Describir Sentimientos y Pensamiento Externamente Orientado lograron el mejor ajuste. Los 
coeficientes alfa oscilaron entre 0,87 y 0,67; las correlaciones medias inter-ítem entre 0,48 y 
0,20; y las correlaciones test-retest tras 6 meses oscilaron entre 0,61 y 0,52. El 18,10% de la 
muestra presentó niveles elevados de alexitimia. La TAS-20-S presentó una adecuada fiabilidad 
así como la tradicional estructura trifactorial, por lo que su uso es ahora recomendable para 
evaluar un aspecto del procesamiento emocional en EM.
© 2013 Asociación Española de Psicología Conductual. Publicado por Elsevier España, S.L.  
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version of the TAS-20 to develop a revised and improved 
Spanish translation of the scale, and to evaluate its 
reliability and factor structure in a sample of patients with 
MS. This is the first study to assess alexithymia in a Spanish 
MS sample.
Method
Participants
Two hundred and sixty-five outpatients with MS who came 
for their routine medical checkups at the University 
Hospital Virgen Macarena in Seville, Spain, were invited to 
participate in this study in 2011. However, 44 patients 
were not enrolled because they declined (14 patients) or 
lacked time to participate (7 patients); or because of the 
following exclusion criteria: cognitive impairment (13 
patients); neurological comorbid conditions (5 patients); 
major psychiatric disorders (1 patient with chronic 
psychosis) or a significant mood disturbance at the time 
of assessment (2 patients); and other special conditions (2 
patients pregnant). The final sample was comprised of 
221 participants (83.4%), who were all diagnosed with 
multiple sclerosis according to the 2010 revised McDonald’s 
criteria (Polman et al., 2011). The participants were 
involved through the convenience sampling technique. 
Sociodemographic data and information about the course 
of MS, functional disability according to the Expanded 
Disability Status Scale (EDSS), and pharmacotherapy were 
collected. The clinical and sociodemographic characteristics 
are presented in Table 1.
Instruments
The TAS-20 is a 20-item self-report instrument with each 
item scored on a 5-point Likert scale (Bagby et al., 1994). 
Total scores range between 20 and 100 with higher scores 
indicating greater degrees of alexithymia. The developers of 
the scale recommend the following empirically established 
cutoff scores: nonalexithymic cases: ≤ 51; borderline cases: 
52-60; alexithymic cases: ≥ 61 (Taylor et al., 1997). The 
English version of the TAS-20 was adapted to the Spanish 
language in an iterative-process (Carretero-Dios & Pérez, 
2005). First, the original English version was translated into 
Spanish by several university researchers in the field of 
clinical psychology, and with expertise in construction and 
adaptation of questionnaires, who also reviewed the existing 
Spanish adaptations of the TAS-20 and made corrections to 
items they thought had been inadequately translated. For 
example, a frequent mistake in translation was the use of 
“explain feelings” as a synonym for “describe feelings” when 
both verbs differentiate between a deeper emotional 
processing – analyze or explain – against a lighter one – 
describe –, and precisely the latter was the alexithymic 
characteristic of interest. Given the importance of reviewing 
the adequacy of a translation with statistical methods (Sireci, 
Yang, Harter, & Ehrlich, 2006), the new Spanish translation 
of the TAS-20 was also influenced by considering the 
inadequate psychometric functioning of some items in the 
earlier Spanish versions. Second, a Spanish-English bilingual 
PhD psychologist, who was familiar with the Spanish and 
American cultures but not given access to the original English 
version of the TAS-20, made a back-traslation of the new 
Spanish translation. Finally, this back-translated English 
version was then reviewed and compared with the original 
English version by the developers of the TAS-20. Moreover, a 
bilingual research assistant working in Canada also compared 
this back-translation with the Spanish version. Some further 
modifications were made until a consensus was reached 
about the final translation. The final Spanish adaptation of 
the scale (the TAS-20-S) was then pilot tested with 20 
patients; the items were read to them to check if the items 
were correctly understood and to identify any difficulties in 
answering them. Only 8 items remained with the same or 
similar translation to the first version of the TAS-20 adapted 
in Spain. 
Procedure
All patients were assessed individually by a trained 
psychologist (EFJ) during their routine checkups at the 
hospital after written informed consent was obtained. The 
TAS-20-S items were read by such psychologist, a method 
that has been used in other studies (Pérez-Rincón et al., 
1997), given the MS patients’ difficulties in understanding 
some of the items when they read the questionnaires by 
themselves. This procedure allowed us to avoid response 
tendencies and the problems with negatively-worded items 
reported in other studies (Loiselle & Cossette, 2001). The 
writing of this manuscript has followed the Hartley’s (2012) 
guidelines. The study was approved by the Ethics Commission 
of Research of the University Hospital Virgen Macarena.
Data analysis
Confirmatory factor analyses were conducted using the 
matrix of polychoric correlations, as was carried out in 
other studies (Gorostiaga, Balluerka, Aritzeta, Haranburu, 
& Alonso-Arbiol, 2011), with Weighted Least Squares Means 
and Variances (WLSMV) estimation (Flora, LaBrish, & 
Chalmers, 2012). The goodness-of-fit indices computed and 
presented according to Hammervold and Olsson’s (2012) 
classification were as follows: chi-square goodness-of-fit 
index; Weighted Root Mean Square Residual (WRMR) was 
selected as a measure of absolute fit and residual-based 
fit; the Tucker–Lewis Index (TLI) and the Comparative Fit 
Index (CFI) were selected as measures of incremental fit; 
and the Root-Mean-Square Error of Approximation (RMSEA) 
along with its 90% confidence interval was chosen as a 
measure of parsimonious fit. All these indices were 
interpreted simultaneously to overcome the limitations of 
each one (Carretero-Dios & Pérez, 2005; Hammervold & 
Olsson, 2012). The following standards were used to assess 
the model fit: a non-significant value of chi-square; WRMR 
≤ 1 (Yu, 2002); TLI and CFI ≥ .90 (Marsh, Hau, & Wen, 2004); 
and RMSEA < .08 (MacCallum, Browne, & Sugawara, 1996). 
Each of the TAS-20 items was specified as an indicator of 
only a single factor.
The following six different factor models were tested and 
compared:
1)  A unidimensional model in which all items load on one 
unique factor (Lambert et al., 1999).
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2)  An oblique two-factor model in which Difficulty Identifying 
Feelings (DIF) and Difficulty Describing Feelings (DDF) 
belong to the same factor (DIDF) and Externally Oriented 
Thinking (EOT) is isolated in another factor (Kooiman et 
al., 2002; Pérez-Rincón et al., 1997). 
3a)  The traditional oblique three-factor model made up of 
DIF, DDF and EOT, according to the developers of the 
TAS-20 (Bagby et al., 1994).
3b)  A comparable hierarchical model was also tested in 
which DIF, DDF, and EOT were specified to indicate a 
second-order factor: Global Alexithymia.
3c)  An alternative oblique three-factor model with DIF and 
DDF belonging to the same factor (DIDF); and EOT divided 
into two separate factors: Pragmatic Thinking (PR) – 
items 5, 8 and 20 – and Lack of Importance of Emotions 
(IM) – items 10, 15, 16, 18, and 19 (Müller et al., 2003).
4)  An oblique four-factor model with DIF, DDF, PR and IM as 
separate factors (Müller et al., 2003). 
To assess internal consistency reliability of the TAS-20-S, 
alpha coefficients and mean inter-item correlations (MICs) 
were computed for the best fitting factor model. A standard 
of .70 or higher was set for alpha coefficients and an 
optimal range of .20 to .40 for MICs (Briggs & Cheek, 1986). 
Finally, 85 of the participants were enrolled to evaluate 
retest reliability; these patients completed the TAS-20-S 
approximately 6 months (M = 5.70 months, SD = 0.99) after 
its initial administration. No missing data were found and 
no data transformations were carried out. All analyses were 
conducted with the program Mplus 6.1 (Muthén & Muthén, 
2011) and the IBM-SPSS 19.0 statistical software package 
(SPSS, Inc., Chicago, Ill) for Windows PC.
Table 1 Clinical and sociodemographic characteristics of the multiple sclerosis patients (n = 221).
 Mean (SD)
Age (in years) 40.61 (9.65)
Months since diagnosis 101.43 (75.28)
Expanded Disability Status Scale (EDSS) 3.04 (1.83)
 % (n)
EDSS 0 4.10 (9)
Mild EDSS level (1-3.5) 61.50 (136)
Moderate EDSS level (4-6.5) 30.80 (68)
Severe EDSS level (> 7) 3.60 (8)
Multiple sclerosis course 
Relapsing remitting 77.80 (172)
Secondary progressive 17.70 (39)
Primary progressive 4.50 (10)
Disease modifying therapy: yes/no 76.90 / 23.1 (170 / 51)
Antidepressant medication: yes/no 27.10 / 72.9 (60 / 161)
Anxiolytic medication: yes/no 25.80 / 74.2 (57 / 164)
Female/male gender 63.03 / 36.7 (140 / 81)
Marital status 
Partner (married or stable relationship) 78.30 (173)
Single 14.09 (33)
Separated/divorced 5.90 (13)
Widow 0.90 (2)
Educational level* 
High 549.50 (110)
Secondary 29.90 (66)
Primary 20.4 (45)
Employment status 
Permanent/transient disability 35.30 (78)
Working 34.40 (76)
Unemployed/students 15.4 (34)
Sick leave 7.20 (16)
Adapted work 2.30 (5)
Housewives 1.80 (4)
Retired 0.50 (1)
*High level: completed university or a high level vocational training program; Secondary level: completed high school or a medium 
level vocational training program; Primary level: did not complete high school.
Note. SD = standard deviation.
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Results
No statistically significant differences were found between 
the participants in the study and the nonparticipants (n = 
44) in the variables of age [F(1, 263) = 0.118, p = .731], gender 
[χ²(1, 265) = 0.104, p = .747], EDSS [F(1, 53.711) = 2.895, 
p = .095], and number of months since MS diagnosis [F(1, 263) 
= 0.473, p = .492]. 
In the participant sample, the mean total TAS-20-S score 
was 46.68 (SD = 14.38); alexithymic cases: 18.1% of sample 
(n = 40), mean 68.15 (SD = 5.24); borderline cases: 20.4% 
of sample (n = 45), mean 57.09 (SD = 2.73); nonalexithymic 
cases: 61.5% of sample (n = 136), mean 36.92 (SD = 7.63).
Confirmatory factor analysis
Factor loadings for each item across models are presented 
in Table 2. All items demonstrated statistically significant 
substantial loadings (≥ .30) on their specified factor across 
models, with the exception of model 1. In model 1, items 
19, 15, 10, 5 and 16 failed to reach this minimal loading 
value. Correlations among factors across models are 
reported in Table 3. Correlations among factors were all 
moderate to large in size, ranging from .29 to .82. Based 
on the goodness-of-fit statistics evaluated (see Table 4), 
models 3a, 3b, and 4 achieved reasonable model fit. 
However, the specified higher-order model (3b) resulted in 
a small non-significant negative residual variance for DDF. 
Fixing this value to zero (resulting in a factor loading of 
1.00) resulted in a reasonably fitting model that is nearly 
identical to the standard three-factor model (3a). All first-
order coefficients were positive and statistically significant 
in this case,1 and the second-order factor loadings for DIF 
and EOT were .79 and .56, respectively (all p < .001). Model 
4 demonstrated a slightly better fit than models 3a and 3b; 
however, the correlation > 1.0 between IM and PR (also 
found in model 3c) is an indication that the two factors are 
not statistically distinguishable, making the results of this 
model inadmissible.2 Overall, the standardized factor 
loadings from the traditional three-factor model (3a) were 
higher in the current study in comparison to those from the 
previous Spanish version of the TAS-20.
Reliability
Table 5 shows the MICs and alpha coefficients for the total 
TAS-20-S and three factor scales for the traditional three-
factor model (3a). The MICs for the total scale and the DDF 
and EOT factor scales are in the recommended range of .20 
to .40, indicating adequate item-to-scale homogeneity. 
Although the MIC for the DIF factor scale is outside this 
Table 2 Standardized factor loadings for each model.
 Model 1 Model 2 Model 3a Model 3c Model 4
Item  DIDF EOT DIF DDF EOT DIDF PR IM DIF DDF PR IM
1 .853 .857  .872   .857   .872   
3 .548 .554  .571   .555   .574   
6 .806 .812  .824   .812   .825   
7 .684 .692  .711   .692   .710   
9 .832 .838  .855   .838   .855   
13 .731 .738  .757   .738   .755   
14 .730 .735  .751   .736   .751   
2 .793 .799   .877  .799    .876  
4 .617 .623   .665  .622    .666  
11 .597 .601   .648  .600    .648  
12 .420 .419   .456  .418    .456  
17 .564 .563   .616  .562    .615  
5 .263  .454   .446  .418    .417 
8 .469  .710   .698  .650    .651 
10 .237  .459   .464   .497    .497
15 .207  .339   .348   .364    .369
16 .287  .463   .459   .488    .469
18 .391  .528   .543   .548    .559
19 .195  .405   .416   .444    .454
20 .406  .640   .634  .593    .593 
Note. DIDF = Difficulty Identifying Feelings together with Difficulty Describing Feelings; DIF = Difficulty Identifying Feelings; DDF = 
Difficulty Describing Feelings; EOT = Externally Oriented Thinking; PR = Pragmatic Thinking; IM = Lack of Importance of Emotions. 
All factor loadings are statistically significant, p < .001.
1Due to space limitations and the fact that factor loadings 
of Model 3b were very similar to those of Model 3a, these 
coefficients are not shown in Table 2 and are available 
upon request.
2The correlation matrix is available upon request from the 
authors.
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optimal range, it is between .10 and .50, which is considered 
acceptable. The alpha coefficients range between .72 and 
.86 for the full scale and DIF and DDF factor scales, but for 
EOT the alpha coefficient is below the criterion of .70. The 
retest correlations for the full scale and three factor scales 
are all significant.
Discussion
In this pioneering study with a multiple sclerosis patient 
sample, our objectives were: a) to evaluate the factor 
structure of an improved Spanish translation of the TAS-20, 
Table 3 Correlations among the factors.
 Model 2 Model 3a Model 3c Model 4
 EOT DDF EOT PR IM DDF PR IM
DIDF .50   .58 .43   
DIF  .82 .41   .82 .54 .29
DDF   .61    .59 .63
EOT        
PR     1.04   1.03
Note. DIF = Difficulty Identifying Feelings; DDF = Difficulty Describing Feelings; EOT = Externally Oriented Thinking; PR = Pragmatic 
Thinking; IM = Lack of Importance of Emotions. 
All correlations are statistically significant, p < .001.
Table 4 Goodness-of-fit indices of the factor models.
 1 2 3a 3b 3c 4 
χ2 599.683 440.767 388.316 388.821 437.819 370.562
df 170 169 167 168 167 164 
p < .001 < .001 < .001 < .001 < .001 < .001 
RMSEA .107 .085 .077 .077 .086 .075 
90% confidence .098-.116 .076-.095 .067-.088 .067 - .087 .076 - .096 .065-.086
CFI .864 .914 .930 .930 .914 .935 
TLI .848 .904 .920 .921 .903 .924 
WRMR 1.483 1.268 1.169 1.174 1.259 1.133 
Note. RMSEA = Root Mean Square Error of Approximation; CFI = Comparative Fit Index; TLI = Tucker Lewis Index; WRMR = Weighted Root 
Mean Square Residual.
Table 5 Alpha coefficients and mean inter-item correlations (MIC) for the 20-item Toronto Alexithymia Scale (TAS-20-S) and 
its factor scales (model 3a).
Factor scales Cronbach’s α MIC Retest reliability
DIF .87 .48 r = .52, p < .001
DDF  .72 .34 r = .61, p < .001
EOT .67 .20 r = .56, p < .001
TAS-20-S total .86 .22 r = .57, p < .001
Note. DIF = Difficulty Identifying Feelings; DDF = Difficulty Describing Feelings; EOT = Externally Oriented Thinking.
which we named the TAS-20-S; and b) to evaluate the 
reliability of the TAS-20-S and its factor scales. 
Regarding the first objective, the three-factor model of 
the TAS-20 was confirmed in the Spanish multiple sclerosis 
patient sample. The traditional correlated three-factor 
model and a higher-order factor model were the best 
fitting, both showing comparable results. Therefore, the 
factor scales Difficulty Identifying Feelings, Difficulty 
Describing Feelings, and Externally Oriented Thinking were 
replicated as core facets of the alexithymia construct 
assessed by the TAS-20 (Taylor et al., 2003). Although the 
use of externally imposed cutoff values to assess the 
goodness of fit of a model has been questioned – e.g., 
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because the widely used Hu and Bentler’s (1999) guidelines 
have sometimes been misinterpreted and considered too 
demanding – (Marsh et al., 2004), in the current study most 
goodness-of-fit indices for both three-factor models (3a 
and 3b) were adequate and acceptable. However, WRMR 
values were slightly above the criterion level of ≤ 1, and 
the chi-square goodness of fit was significant for all models. 
Although the four-factor model showed a slightly better fit, 
two factors (PR and IM) were statistically indistinguishable 
(correlation > 1). Therefore, the differentiation of the EOT 
factor into two separate factor scales was not justified in 
this sample in contrast to results obtained in some studies 
conducted with samples of patients with other diagnoses 
(Müller et al., 2003). 
The current study included the recommended incremental 
fit indices (TLI and CFI), which were not computed in 
earlier confirmatory factor analytic studies of Spanish 
adaptations of the TAS-20 (Loiselle & Cossette, 2001; Páez 
et al., 1999). These indices are currently regarded as 
essential for assessing goodness of fit (Hu & Bentler, 1999) 
because TLI and CFI are relatively unaffected by sample 
size, and both detect model misspecification (Jackson, 
Gillaspy, & Purc-Stephenson, 2009). Although the CFI and 
TLI values in the MS patient sample did not reach the level 
of ≥ .95, which is considered acceptable according to Hu 
and Bentler’s (1999) demanding guidelines, relaxing the 
criterion standard to ≥ .90 resulted in these fit indices 
indicating an adequate fit (Marsh et al., 2004). Moreover, 
the TLI and CFI values obtained in the current study exceed 
values reported in earlier studies for Dutch, Italian, 
Japanese, and Mandarin translations of the TAS-20 (Taylor 
et al., 2003; Zhu et al., 2007).
As was found when an improved Greek adaptation of the 
TAS-20 was developed (Tsaousis et al., 2010), the values of 
the goodness-of-fit indices for the TAS-20-S were better 
than those reported for earlier Spanish versions of the scale 
(Páez et al., 1999), and also supported the traditional 
three-factor model rather than a two-factor model (Pérez-
Rincón et al., 1997). Moreover, regarding the three-factor 
model 3a, the factor loadings of 10 of the 12 items modified 
were higher in the current revised Spanish version in 
comparison to the first Spanish version of the TAS-20 
administered to samples in Spain and Mexico (Martínez-
Sánchez, 1996; Páez et al., 1999). This is consistent with 
other studies showing that the use of both judgmental and 
statistical techniques to ensure item comparability across 
languages can improve the psychometric properties of 
psychological measures (Sireci et al., 2006). 
The estimates of internal consistency reliability were 
good for the total TAS-20-S and for the DIF and DDF factor 
scales, with particularly high alpha coefficients for DIF 
and the total scale. Although the alpha coefficient for the 
EOT factor scale was below the recommended standard of 
.70, and questionable according to George and Mallery 
(2003), the total scale and the DDF and EOT factor scales 
were within the optimal range of .20 to .40 for the mean 
inter-item correlations (MICs), which is a more appropriate 
index of a scale’s cohesiveness (Briggs & Cheek, 1986). 
Moreover, the alpha coefficient for EOT was higher than 
has been reported for most other language adaptations of 
the TAS-20 (Taylor et al., 2003; Tsaousis et al., 2010; Zhu 
et al., 2007). Although the MIC for the DIF factor scale 
was outside the optimal range, it was less than .50, which 
is considered acceptable for multifactor scales (Briggs & 
Cheek, 1986). Thus all three factor scales of the TAS-20-S 
can be considered homogeneous, and can be scored along 
with the TAS-20-S total score in studies with MS 
populations. 
Although retest reliability of the TAS-20-S was 
demonstrated over a 6-month interval, the correlations 
were lower in magnitude than those reported in other 
studies with medical patient samples and with a similar 
time interval between assessments. For example, the 
retest correlation of the total TAS-20 was .66 in a sample 
of women with breast cancer after a 6-month follow-up 
(Luminet, Rokbani, Ogez, & Jadoulle, 2007). The lower 
temporal stability of the TAS-20-S in the current study may 
possibly be accounted for by the neurodegenerative nature 
and variable course of MS.
The prevalence of alexithymic cases in this larger MS 
sample than previously investigated was 18.1% and 20.4% 
for borderline cases, which is in the range found in two 
other studies with MS patients – 13.8% in Italy (Bodini et al., 
2008) and 23.2% in France (Gay et al., 2010) – using the 
same cut-off points. The prevalence rates of alexithymia 
are similar to the prevalence rates of depression in MS 
(Wood et al., 2013); hence the problems in emotional 
processing are not negligible in MS and neuropsychological 
interventions to address these impairments are required 
(Wingbermühle et al., 2012). Other research with various 
clinical populations has shown that treatments aimed at 
reducing alexithymia can result in better biopsychosocial 
outcomes (Beresnevaité, 2000; Melin, Thulesius, & Persson, 
2010; Tulipani et al., 2010). 
In conclusion, the results of the current study support 
the factorial validity of the TAS-20-S and indicate that it is 
a reliable instrument that can be used to assess an important 
aspect of emotional processing in MS populations. In 
particular, the scale might be used to investigate the 
clinical relevance of each of the three facets of the 
alexithymia construct in MS that may suggest a need for 
specific treatment interventions. Further research is 
needed to evaluate the psychometric properties of the TAS-
20-S in community and other clinical samples, including 
assessment of the convergent and discriminant validity of 
the scale3. 
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